|Articles|November 4, 2022
Supplements and Featured Publications
- Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
- Volume 28
- Issue 13
Participating Faculty: Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
Author(s)Thomas Ciulla, MD, MBA, Steven Yeh, MD
Advertisement
FACULTY
Thomas Ciulla, MD, MBA
Chief Medical Officer & Chief Development Officer Clearside Biomedical
Alpharetta, GA
Volunteer Clinical Professor
Indiana University School of Medicine Indianapolis, Indiana
Steven Yeh, MD
Professor of Ophthalmology Truhlsen Eye Institute
University of Nebraska Medical Center Omaha, NE
FACULTY DISCLOSURES
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Thomas Ciulla, MD, MBA
STOCK OWNERSHIP
Clearside Biomedical
EMPLOYMENT
Clearside Biomedical
Steven Yeh, MD
CONSULTANCIES OR PAID ADVISORY BOARDS
Bausch + Lomb, Adverum Biotechnologies, REGENXBIO
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
From CAR T-Cell Therapy to ADCs: Tackling Oncology Access Gaps
5
